Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 11, keine Gesamtzahl für „CellCept“
Suchtreffer
Begriffe & Kennungen
CellCept · 4.8 · Cases of pure red cell aplasia (PRCA) have been reported in patients treated with mycophenolate mofetil (see s
Eintrag öffnenCellCept · 4.8 · Cases of pure red cell aplasia (PRCA) have been reported in patients treated with mycophenolate mofetil (see s
Eintrag öffnenCellCept · 4.8 · Cases of pure red cell aplasia (PRCA) have been reported in patients treated with mycophenolate mofetil (see s
Eintrag öffnenCellCept · 4.8 · Congenital disorders Congenital malformations have been observed post-marketing in children of patients expose
Eintrag öffnenCellCept · 4.8 · Congenital disorders Congenital malformations have been observed post-marketing in children of patients expose
Eintrag öffnenCellCept · 4.8 · Congenital disorders Congenital malformations have been observed post-marketing in children of patients expose
Eintrag öffnenCellCept · 4.8 · De novo purine synthesis inhibitors associated acute inflammatory syndrome has been described from post-market
Eintrag öffnenCellCept · 4.8 · De novo purine synthesis inhibitors associated acute inflammatory syndrome has been described from post-market
Eintrag öffnenCellCept · 4.8 · De novo purine synthesis inhibitors associated acute inflammatory syndrome has been described from post-market
Eintrag öffnenCellCept · 4.8 · De novo purine synthesis inhibitors associated acute inflammatory syndrome has been described from post-market
Eintrag öffnenCellCept · 4.8 · Description of selected adverse reactions
Eintrag öffnenCellCept · 4.8 · Description of selected adverse reactions
Eintrag öffnenCellCept · 4.8 · Description of selected adverse reactions
Eintrag öffnenCellCept · 4.8 · Diarrhoea (up to 52.6%), leukopenia (up to 45.8%), bacterial infections (up to 39.9%) and vomiting (up to 39.1
Eintrag öffnenCellCept · 4.8 · Diarrhoea (up to 52.6%), leukopenia (up to 45.8%), bacterial infections (up to 39.9%) and vomiting (up to 39.1
Eintrag öffnenCellCept · 4.8 · Diarrhoea (up to 52.6%), leukopenia (up to 45.8%), bacterial infections (up to 39.9%) and vomiting (up to 39.1
Eintrag öffnenCellCept · 4.8 · Diarrhoea (up to 52.6%), leukopenia (up to 45.8%), bacterial infections (up to 39.9%) and vomiting (up to 39.1
Eintrag öffnenCellCept · 4.8 · Elderly Elderly patients (≥ 65 years) may generally be at increased risk of adverse reactions due to immunosup
Eintrag öffnenCellCept · 4.8 · Elderly Elderly patients (≥ 65 years) may generally be at increased risk of adverse reactions due to immunosup
Eintrag öffnenCellCept · 4.8 · Elderly Elderly patients (≥ 65 years) may generally be at increased risk of adverse reactions due to immunosup
Eintrag öffnen